Abingworth’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $108K | Hold |
9,620
| – | – | 0.04% | 17 |
|
|
2022
Q3 | $127K | Hold |
9,620
| – | – | 0.04% | 18 |
|
|
2022
Q2 | $121K | Hold |
9,620
| – | – | 0.04% | 20 |
|
|
2022
Q1 | $553K | Hold |
9,620
| – | – | 0.16% | 17 |
|
|
2021
Q4 | $1.14M | Hold |
9,620
| – | – | 0.28% | 16 |
|
|
2021
Q3 | $1.91M | Hold |
9,620
| – | – | 0.43% | 16 |
|
|
2021
Q2 | $1.67M | Hold |
9,620
| – | – | 0.52% | 14 |
|
|
2021
Q1 | $1.9M | Hold |
9,620
| – | – | 0.65% | 14 |
|
|
2020
Q4 | $1.89M | Hold |
9,620
| – | – | 0.65% | 11 |
|
|
2020
Q3 | $1.7M | Hold |
9,620
| – | – | 0.36% | 13 |
|
|
2020
Q2 | $2.22M | Hold |
9,620
| – | – | 0.62% | 13 |
|
|
2020
Q1 | $1.1M | Hold |
9,620
| – | – | 0.73% | 13 |
|
|
2019
Q4 | $1.84M | Hold |
9,620
| – | – | 0.89% | 10 |
|
|
2019
Q3 | $1.85M | Hold |
9,620
| – | – | 1.17% | 8 |
|
|
2019
Q2 | $1.64M | Hold |
9,620
| – | – | 0.63% | 9 |
|
|
2019
Q1 | $1.93M | Buy |
+9,620
| New | +$1.93M | 1.73% | 9 |
|